Effect of sodium glucose cotransporter 2 inhibitors on cardiac function and cardiovascular outcome: a systematic review | Cardiovascular Ultrasound | Full Text
Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care | Diabetes Technology & Therapeutics
![sglt-2_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/sglt2.png "sglt-2_inhibitors [TUSOM | Pharmwiki]")
sglt-2_inhibitors [TUSOM | Pharmwiki]
Sodium-Glucose Cotransporter 2 Inhibitors: An Overview
Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 Inhibitor Canagliflozin with SGLT1 and SGLT2: Inhibition Kinetics, Sidedness of Action, and Transporter-Associated Incorporation Accounting for its Pharmacodynamic and Pharmacokinetic Features ...
SGLT2 Inhibitor–Induced Euglycemic Diabetic Ketoacidosis: A Case Report - Kidney Medicine
UK Kidney Association releases guideline on SGLT2 inhibitor use - DiabetesontheNet
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial -
SGLT2 Inhibitors in Heart Failure: DAPA-HF & EMPEROR Trials
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 ( SGLT2) Inhibitors: A State-of-the-Art Review - ScienceDirect
SGLT2 Inhibitors: A New Class of Diabetes Medications
SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition - ScienceDirect
SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism | SpringerLink
The role of SGLT2 inhibitors in Type 2 Diabetes | BJFM
Schematic representation of the clinical effects of SGLT2 inhibitor.... | Download Scientific Diagram
SGLT2 Inhibitors – Diabetologia
Is an SGLT2 inhibitor right for your patient with type 2 diabetes? | Diabetes Hub
Comparison of SGLT2 inhibitor and GLP-1 receptor agonist as addition metformin or metformin plus sulfonylurea: systematic review with indirect comparison meta-analysis - Virtual Meeting | EASD
JCI Insight - Hyperglycemia induces skeletal muscle atrophy via a WWP1/KLF15 axis
SGLT2 inhibitors: a narrative review of efficacy and safety
Potential Mechanisms of Sodium-Glucose Co-Transporter 2 Inhibitor-Related Cardiovascular Benefits - American Journal of Cardiology
References in SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis - Clinical Therapeutics
Summary of Heart Failure Outcomes in SGLT2 Inhibitor Clinical Studies | Radcliffe Cardiology
Sodium-Glucose Cotransporter-2 inhibitors are potential therapeutic agents for treatment of non-diabetic heart failure patients - Journal of Cardiology
SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease | Nature Communications
Scheme representing the proposed effects of SGLT2 inhibitor on NLRP3... | Download Scientific Diagram
SGLT2 inhibitors: molecular design and potential differences in effect - Kidney International
